Catalyst Pharmaceutical Partners Inc (NASDAQ:CPRX)

Data as of Jan 30
 +0.23 / +6.73%
Today’s Change
Today|||52-Week Range
Health Technology
Pharmaceuticals: Other

Company Description

Catalyst Pharmaceutical Partners, Inc. is a development-stage specialty pharmaceutical company, which focuses on the development and commercialization of prescription drugs targeting addiction and diseases of the central nervous system with a focus on the treatment of drug addiction and epilepsy. The company has two products in development, and is currently evaluating its lead product GABA aminotransferase inhibitor candidate, CPP-109 (vigabatrin) for the treatment of cocaine addiction and it also expects to evaluate CPP-109 for the treatment of other addictions. It also develops CPP-115, another GABA aminotransferase inhibitor that is more potent than vigabatrin and has reduced side effects from those associated with vigabatrin. Catalyst Pharmaceutical Partners was founded by McEnany J. Patrick and Huckel E. Hubert in January 2002 and is headquartered in Coral Gables, FL.

Contact Information

Catalyst Pharmaceutical Partners, Inc.
355 Alhambra Circle
Coral Gables Florida 33134
P:(305) 529-2522
Investor Relations:



Other institutional30.12%
Individual stakeholders20.07%
Mutual fund holders12.09%

Top Executives

Patrick J. McEnanyChairman, President & Chief Executive Officer
Steven R. MillerChief Operating & Scientific Officer
Alicia GrandeChief Financial Officer, Treasurer & VP
Charles W. GorodetzkyChief Medical Officer
David D. MuthChief Commercial Officer & Executive VP

Most stock quote data provided by BATS. Market indices are shown in real time, except for the DJIA, which is delayed by two minutes. All times are ET. Disclaimer.

Morningstar: © 2015 Morningstar, Inc. All Rights Reserved.

Factset: FactSet Research Systems Inc. 2015. All rights reserved.

Chicago Mercantile Association: Certain market data is the property of Chicago Mercantile Exchange Inc. and its licensors. All rights reserved.

Dow Jones: The Dow Jones branded indices are proprietary to and are calculated, distributed and marketed by DJI Opco, a subsidiary of S&P Dow Jones Indices LLC and have been licensed for use to S&P Opco, LLC and CNN. Standard & Poor's and S&P are registered trademarks of Standard & Poor’s Financial Services LLC and Dow Jones is a registered trademark of Dow Jones Trademark Holdings LLC. All content of the Dow Jones branded indices © S&P Dow Jones Indices LLC 2015 and/or its affiliates.